4-氨基甲酰双环[2.2.2]辛烷-1-羧酸 | 1160591-75-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 4-氨基甲酰双环[2.2.2]辛烷-1-羧酸
• 英文名称: 4-Carbamoylbicyclo[2.2.2]octane-1-carboxylic acid
• CAS: 1160591-75-2
• 化学式: C₁₀H₁₅NO₃
• 分子量: 197.23
• InChiKey: QEKBJHIBPLRQFD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  80.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• [EN] HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS<br/>[FR] SULFONES HÉTÉROCYCLIQUES COMME MODULATEURS DE ROR GAMMA
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018071620A1

  公开（公告）日：2018-04-19

  There are described RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ Gamma activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ Gamma activity, for example, autoimmune and/or inflammatory disorders.

  这里描述了公式(I)的RORγ调节剂，或其立体异构体、互变异构体、药用可接受的盐、溶剂化物或前药，其中所有取代基都在此定义。还提供了包含相同成分的药物组合物。这类化合物和组合物在调节细胞中RORγ Gamma活性的方法和治疗因调节RORγ Gamma活性而可从治疗中受益的疾病或病症的患者的方法中是有用的，例如，自身免疫和/或炎症紊乱。
• Gut microsomal triglyceride transport protein inhibitors
  申请人：Vu Chi B.

  公开号：US20080249130A1

  公开（公告）日：2008-10-09

  Compounds represented by formula (I): are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.

  化学式（I）所代表的化合物是肠道微粒体甘油三酯转移蛋白的抑制剂。这些化合物在治疗糖尿病和肥胖等疾病或病况的患者以及患有这些疾病或病况的风险患者中非常有用。
• Heterocyclic sulfones as ROR gamma modulators
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10934286B2

  公开（公告）日：2021-03-02

  There are described RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ Gamma activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ Gamma activity, for example, autoimmune and/or inflammatory disorders.

  本文描述了式 (I) 的 RORγ 调节剂或其立体异构体、同系物、药学上可接受的盐、溶液或原药，其中所有取代基均在本文中定义。此外，还提供了包含上述化合物的药物组合物。此类化合物和组合物可用于调节细胞中RORγ Gamma活性的方法和治疗患有疾病或失调的受试者的方法，其中受试者将从调节RORγ Gamma活性中获得治疗益处，例如自身免疫和/或炎症性失调。
• SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
  申请人：Bristol-Myers Squibb Company

  公开号：EP3924329A2

  公开（公告）日：2021-12-22
• HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20190300523A1

  公开（公告）日：2019-10-03

  There are described RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ Gamma activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ Gamma activity, for example, autoimmune and/or inflammatory disorders.